The presence of clinical T stage ≥ T2c (TNM Staging System, 8th Ed. [4]), Gleason score (GS) ≥ 8, and prostate-specific antigen (PSA) > 20 ng/mL frames this case as high-risk PC. The gene discussed is KLK3; the disease is pachyonychia congenita.